Mental status of females with a FMR1 gene full mutation by Vries, B.B. de et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/22480
 
 
 
Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
A m .] .  Hum. Genet. 58:1025-1032 , 1996
Mental Status of Females with an FMR1  Gene Full Mutation
B. B. A. de Vries,1 A. M. Wiegers,3 A. P. T. Smits,4 S. Mohkamsmg,1 H. J. Duivenvoorden,2 
J.-P. Fryns,5 L. M. G. Curfs,3'* D. J. J. Hailey,1 B. A. Oostra,1 A. M. W. van den Ouweland,1 
and M. F. Niermeijer1
Departments of ’ Clinical Genetics and 2Medica! Psychology and Psychotherapy/ University Hospital Dijkzigt and Erasmus University/ 
Rotterdam; 3Researcb Department Observation Centre De Hondsberg, Oisterwijk; 4Department of Human Genetics, University Hospital 
Nijmegen, Nijmegen; and 5Division of Human Genetics, University Hospital Gasthuisberg, Leuven, Belgium
Summary
The cloning of the FMR1 gene enables molecular diag­
nosis in patients and in carriers (male and female) of 
this X-linked mental retardation disorder. Unlike most 
X-linked disorders, a considerable proportion of the fe­
male carriers of a full mutation in the FMR1 gene is 
affected. In this study, the intelligence quotients (IQs) 
were ascertained by the Wechsler Adult Intelligence 
Scale in 33 adult females with a full mutation, with 28 
first-degree adult female relatives (mainly sisters) with­
out a full mutation as controls. Seventy-one percent of 
the females with a full mutation had IQ scores below 
85. In paired analysis, no significant correlation could 
be detected between the IQs of the females with a full 
mutation and those of their first-degree female relatives, 
reflecting a dominant effect of the FMR1 gene full muta­
tion in the mental development of females. Considering 
females with a full mutation only, we observed a signifi­
cant relation between the proportion of normal FMR1 
alleles on the active X chromosome and IQ. We present 
a model to explain this relationship.
Introduction
The fragile X syndrome is the most common single cause 
of inherited mental retardation, affecting (according to 
earlier estimates) ±1/1,250 males and ±1/2,000 females 
(Webb et al. 1986). Recently, a lower incidence was 
reported of ±1/4,000 for males (Turner et al., in press). 
A fraction of the X-chromosomes in affected males 
show, on cytogenetic testing, a fragile site at Xq27 when
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cells are cultured in a folic acid-deficient medium (Lubs
1969; Sutherland 1977).
The cloning of the FMR1 gene enabled direct DNA 
diagnosis in both male and female fragile X patients (Fu
et al. 1991; Oberle et al. 1991; Verkerk et al. 1991; Yu 
et al. 1991). The FMR1 gene contains a variably sized 
CGG trinucleotide repeat at the 5' end, which has a 
length of between 6 and 53 repeats in normal individu­
als. Patients have >200 CGG repeats, the so-called full 
mutation, which is associated with methylation of a 
CpG island upstream of the FMR1 gene and with ab­
sence of gene transcription (Oberle et aL 1991; Pieretti 
et al. 1991). Normal carrier males and females, with an 
exception for normal females with a full mutation, have 
an intermediate repeat number of between 43 and 200, 
the so-called premutation, with an unmethylated CpG 
island in front of the FMR1 gene and normal transcrip­
tion (Pieretti et al. 1991).
The fragile X syndrome is transmitted as an X-linked 
semidominant disorder, since males and females may be 
affected. In earlier studies, the cognitive profile in fe­
males with the fragile X syndrome has been related to 
fragile X chromosome expression. Some groups found 
a significantly negative relationship between the percent­
age of fragile X expression and intelligence quotient (IQ) 
(Chudley et al. 1983; Wilhelm et al. 1988). Others found 
no such relation between IQ and fragility (taking ^ 2 %  
of fragile X cells as evidence for the carrier status)
(Cronister et al. 1991).
Before the cloning of the gene, the reported incidence 
of intellectual deficits (IQ <  85) among heterozygous 
females ranged from 35% to 53% (Sherman et al. '1985; 
Hagerman et a l  1992). Besides the limitations of cytoge­
netic methods for the diagnosis of heterozygosity in fe­
males, most of those earlier studies also lacked an ade­
quate control group. Recent studies based on DNA 
mutation analysis show mental impairment in 5 2 % -  
82% of the females with a full mutation (Rousseau et
al. 1991a} 1991 b; Smits et al. 1994; Taylor et al. 1994),
whereas Reiss et al. (1993) showed that the premutation 
in females did not affect their intellectual development.
Molecular analysis of the FMR1 gene in carrier fe-
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males enabled a reliable determ ination of X-inactiva- 
tion. A relation between the ratio of active normal X 
chromosomes to norm al inactive X chromosomes and 
full-scale IQ was r e p or t  e d (Rousseau e t a L 1991 b; A l> Fu 11 m utatio n
rams et al. 1994). Abrams et al. (1994) reported a rela­
tion between the size of the F M R l gene mutation and Normal Inactive (Nl)
IQ, which had also been observed in a multicenter study 
by Rousseau et al. (1994). However, another study 
could not confirm this observation (Taylor et al, 1994).
We report the IQs and profiles in females with the full Normal Active (NA) 
FMR1 mutation in com parison with their first-degree
female relatives w ithou t a full m utation. Second, the size 
of the full mutation and the proportion  of normal active 
X chromosomes in leukocytes were studied in relation 
to IQ and age of the females w ith a full mutation.
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Figure 1 Analysis with probe pP2 of Hwdlll- and /v^I-digested 
DNA of two females with a full mutation, reflecting the proportion of 
normal FMRl alleles on the active X chromosomes (NA) and normal 
FMR1 alleles on the inactive X chromosomes (NI).
Subjects, Material, and Methods
the manufacturer’s instructions, separated by gel electro-
Subjects and Controls phoresis, and subjected to Southern blot analysis ac-
Thirty-three females with a full m utation in the F M R 1 cording to standard procedures (Sambrook et al. 1989).
gene, aged 2 0 -7 0  years (mean 39,7 ±  14.4 years), from The probe was labeled by the random  oligonucleotide
23 fragile X families were included. All families were priming method (Feinberg and Vogelstein 1983). After
ascertained through a male index patient (usually a first- prehybridization and hybridization, the filters were
degree relative) and were studied after informed consent washed to 0.1 X SSC at 65°C prior to autoradiography
was obtained. The study was approved by the Medical (Sambrook et al. 1989). Several autoradiograms (2 -3 )
Ethical Committee of the University Hospital, Rotter- with different exposure times were made.
dam. One female did not w an t to participate (not 
counted). Twenty-one females were paired to a sister 
with a normal FMR1 genotype (aged 2 2 -7 2  years, mean 
41.3 ±  14.5 years). In case m ore female control sibs
The size of the full mutation was estimated by averag­
ing the smallest and largest detectable expansion. Sizes 
were estimated by determining the beginning and the 
end of the smear on Southern blot in carriers of the full
were available, the female with the best age match was mutation (fig. 1 ).
included in the study. In the absence of a control sister, The percentages of normal FM R 1 alleles on the active
the m other with a p rem utation  was included as a control X chromosomes (NA) and normal FM R l alleles on the 
(;/ = 7; aged 4 8 -6 8  years, mean 54 .7  ± 7.1 years). For inactive X chromosomes (NI) were ascertained by densi­
tometry using a scanner (HP, scanjet IICX). The propor­
tion of normal FM R l alleles on the active X chrom o­
some (NA) versus normal FMR1 alleles on the inactive
five females with a full m utation  from large sibships, a 
unique control was not available, because every control 
had only been used once. Those five females were ex­
cluded from paired analysis (leaving 28 pairs) but were 
included in the molecular association studies.
Determination o f  IQ Levels
X chromosome (NI) was calculated using the equation: 
NA/(NA -1~ NI) (fig. 1 ) (Rousseau et al. 19916).
In females with a mosaic pattern of the FM Rl gene 
mutation (full mutation with an additional premuta-
In all 6,1 females, the IQ and profile were ascertained tion), estimation of the size of the expansion and the 
by using the Dutch version of the Wechsler Adult Intelli- proportion of normal active X will be hampered by the 
gence Scale. (Stinissen et al, 1970). IQ testing was per- additional premutation. Therefore, females with a pre­
formed at the home of females by one examiner (A.W.) mutation in addition to the full mutation (n = 6 ) were 
who was not informed abou t the genetic status of the excluded from the comparison of the size of the full
mutation and the X-inactivation ratio with IQ scores.women.
Data Analysis
A paired i-test for continuous data was applied to test 
for significant differences between the female carriers 
of the full mutation and their controls. The bivariate 
al. 1988). DNA (8 |LLg) was digested to completion with relationship between variables was estimated by means 
the restriction enzymes H m dlll and  Engl according to of Pearson’s prod net-moment correlation coefficient (r).
DNA Analysis
The intragenic D N A  probe pP2 was used for DNA 
analysis of the FMR1 gene (O ostra et al. 1993). Geno­
mic DNA was isolated from  blood leukocytes (Miller et
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Table 1
Summary o f  the IQ Data o f  the Subjects and Controls
Su b jec ts Pa ir e d  C o n t r o l  F ir s t -D e g r e e  R e l a t iv e s
F M a Only P M b + F M a Nc P M b
(n = 27) (n = 6) [n =  21) (» =  7)
Mean SD Mean SD Mean SD Mean SD
Age (years) 39.1 13.7 42.3 18.1 41.3 14.5 52.3 7.1
FSIQ 74.1 18.4 84.2 26.8 116.0 18.4 111.6 22.5
PIQ 81.9 19.7 90.0 28.9 119.1 18.8 111.4 23.7
VIQ 72.3 16.3 82.2 22.1 111.2 18.0 110.3 19.2
Proportion normal active X .71 .17 f  * w T •  * •  i  • *  ■ f 1 1 » i  t  f
;1 Full-mutation FMR1 gene. 
h Premutation FMR1 gene. 
c Normal FMR'I gene.
This correlation coefficient was considered to be an indi­
cator of relative importance, while the corresponding 
P value represents the level of significance statistically. 
Adjusting for age, the partial correlation coefficient was 
the indicator of relative importance.
Results
IQ and Profile in Females with the Full Mutation 
versus Controls
The mean full-scale IQ (FSIQ), performance IQ (PIQ), 
and verbal IQ (VIQ) of the different groups studied are 
shown in table 1 . The 28 female carriers of a full muta­
tion had significantly lower mean FSIQ, PIQ, and VIQ 
scores than their paired controls with a normal FMR1 
gene or with a premutation (for all means P <  .001, 
paired-sample i-test).
There was no significant difference of FSIQ between 
the females with a full mutation only (n = 27) and the 
females with a full mutation and an additional premuta­
tion, the so-called mosaics (n — 6 ) (r = .22; P = .21; 
table 1). Also, no significant difference of FSIQ, PIQ, 
and VIQ was observed between the females with a nor­
mal FMR1 genotype and the females with a premutation 
(r =  - .1 ,  P =  .61; r = - .1 7 ,  P = .39, respectively, r 
= - .0 2 ,  P = .9).
Paired Analysis: Females with a Full Mutation 
Compared with the Controls
In figure 2, each pair (female with a full mutation and 
control) and each female’s IQ are shown. In the group of 
28 pairs, 20 (71%) of 28 carriers of the full mutation had 
an IQ <85 points. When the more strict criteria for mental 
retardation (IQ <  70 points) was used, 14 (50%) of 28 
carriers of the full mutation were mentally retarded, 
whereas none of the control females had an IQ <70 points.
Sixteen (57%) of 28 carriers of the full mutation 
scored >30  IQ points (2 SD) lower than their control. 
This ratio remained nearly unchanged when only the 
21 sister-sister pairs are considered (62%). Remarkably, 
two females with the full mutation had a higher IQ 
than did their controls (fig. 2). No significant correlation 
could be detected between the FSIQ of the females with 
the full mutation and the FSIQ of the controls (r = .22; 
P — .27). Likewise, there was no significant correlation 
for the VIQ of the females with a full mutation and the 
VIQ of the controls (r = .07; P — .74), but the PIQ 
correlation was significant (r = .39, P = .04).
The Size o f the FMR'I Gene Mutation and Mental 
Status in Females with the Full Mutation Only
For females with a full mutation, only the FSIQ, PIQ, 
and VIQ scores were negatively related with age (r
pair NR
Figure 2 IQ level of the females with a full mutation (filled or 
2/3~filled symbols) compared with their first-degree relatives (open 
symbols). Females with full mutation only are represented by filled 
circles, females with a premutation and a full mutation by 2/3-iiUed 
circles, sisters with normal FMR’I genes by open circles, and mothers 
with a premutation by open circles with a dot.
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Figure 3 Average expansion size of the full mutation in the 
FMR1 gene related to the FSIQ in females with a full mutation only.
= —.43, P = .03; r  = —.39, P = .05; and r — —.43, P
= .03, respectively). Therefore, the further data were, in 
addition, analyzed with adjustment for this age-depen­
dent effect. Since the results of those analyses did not 
differ from the analyses without adjustment for age, we 
choose to present only unadjusted data.
The mean of the average sizes of the full mutation 
was 1.6 ±  0.6 kb (n = 27; females with full mutation 
only). N o significant relation was found (r = —.16; P 
= .42) between average size of the full mutation and 
FSIQ (fig. 3), or with one of the subtests, PIQ and VIQ 
(r = — .19, P = .34; and r = — .13, P = .52, respectively). 
A similar result was observed with the smallest or largest 
size of the full mutation (data not shown).
The Proportion o f Normal FMR1 Alleles on the Active 
X Chromosome and Mental Status in Females with the 
Full Mutation Only
The average of the proportions of the normal FMR1 
alleles on the active X chromosome (.71 ± .17) in fe­
males with a full mutation only, was significantly > .5  
(n — 27; P .001). As an internal control, we measured 
the control females with normal FMR1 genes (w = 21) 
who showed .50 ±  .09 X-inactivation.
In figure 4, the proportion of normal FMR1 alleles 
on the active X chromosome in relation to FSIQ is 
shown for females with a full mutation only. The (mod­
erate) relation between the proportion of normal FMR1 
alleles on the active X chromosome and FSIQ is signifi­
cant (r = .45; P = .02). The relation with the proportion 
normal active X was significant for the PIQ (r = .56; P 
= .003). However, a significant relation between the 
proportion of normal active X and VIQ was not ob­
served (r = .31; P = .1 1 ).
No significant relation could be detected between the
proportion normal active X and age in the 27 females
i
with a full mutation only (r = — .14; P = .50; data not 
shown).
Discussion
The Full Mutation in FMR1 Cene in Females Has a 
Dominant Effect over Other Factors Involved in 
Intellectual Development
In the present study, 71% (20/28) of the females with 
a full mutation in the FMR1 gene had IQ scores < 85 , 
representing borderline or mild/moderate retardation. 
Other groups also using DNA analysis of the FMR1 
gene reported lower percentages, varying from 52%  to 
65%, of mental impairment (IQ <  85) among the fe­
males with a full mutation (Rousseau et al. 1991b., 1994; 
Taylor et al. 1994) (table 2), except for Smits et al. 
(1994) who reported 82%. However, in three of these 
studies, the mental development was clinically estimated 
without accurate IQ testing (Rousseau et al. 1991&,
1994; Smits et al. 1994).
Using strict criteria for mental retardation (i.e., IQ 
< 7 0  points), 50% (14/28) of the females with a full 
mutation in this study were mentally retarded. This is 
higher than the observation of Taylor et al. (1994), who 
reported 22% (5/23) of the females to have an IQ <70. 
Their results might be biased by the use of four different 
IQ tests and the low average age of the subjects they 
studied. Further, they could not exclude an ascertain­
ment bias because of “unavoidable selection for motiva­
tion to come to the clinic’5 (p. 513), which is a major 
problem in several comparable studies. The present 
study avoided such a bias, both by selecting the families 
through a male index patient and by visiting the families 
at their homes. Although the possibility that females 
with a full mutation, ascertained through a male index 
patient, might be functioning on a different cognitive 
level as females with a full mutation without an affected, 
first-degree, male relative might be conceivable, at pres­
ent no difference of this type is known.
The first-degree female relatives without a full mutation 
in the FMR1 gene (mainly sisters without an FMR1 gene
Am. J. Hum. Genet. 58:1025—1032, 1996
Proportion of normal active X
Figure 4 Proportion of normal FMR1 alleles on the active X 
chromosome related to FSIQ in females with a full mutation only.
de Vries et al.: Mental Status and FMR1 Mutation 1029
Table 2
Summary of Molecular and IQ Data in Female Carriers of the Full Mutation: Overview of the Literature and the Present Study
N
Age
(years) Controls IQ Test
IQ <  85 
(%)
Size of FMa 
to IQ
Relationship
X inactivationb 
to IQ
X inactivationb 
to Age
Rousseau et al. (1991) 27 All Women PMC Clinical estimate 52 ?w Yes (+) Yes ( + )
(France)
Taylor et al. (1994) 23 3-58 Mothers Test (4)d 65 No No Yes ( + )
(Denver, USA)
Abrams et al. (1994)c 31 4 -2 7 Mothers 
(4* fathers)
Test (2)d ?* Yes (-) Yes (+) No
Reiss et al. (1995)° 
(Baltimore, USA)
29 6 -1 7 Mothers + 
fathers
Wechsler 
Intelligence 
Scale for 
Children
?
• No Yes ( + ) ?«
Rousseau et al. (1994)
(collaborative)
170 All Women Nf 
and PMC
Clinical estimate 59 Yes (-) No Yes ( + )
Present study 33 20-70 Sisters
(+mothers)
Weschler Adult 
Intelligence 
Scale
71 No Yes (+) No8
NOTE.— Minus sign ( - )  or plus sign (+) correspond to negative or positive correlation, respectively. 
a Full-mutation FMR1 gene.
b Proportion of normal active X, as described by Rousseau et al. [199 1b ) .  
c Premutation FMR'l gene. 
d Number of different IQ tests used. 
e Study groups partly overlap. 
f Normal FMR1 gene. 
g Adults only.
mutation) served as references in this study, allowing an 
intrafamilial assessment of the effect of the full mutation. 
The effect of the full FMR1 mutation is reflected in the 
IQ difference between females with the full mutation and 
their controls. Fifty-seven percent (16/28) of the women 
with a full mutation scored significantly lower (>30 
points) than their control, which indicates a dominant ef­
fect of the full mutation in the FMR1 gene over shared 
environmental and genetic factors involved in mental de­
velopment. This is supported by the observation that both 
FSIQ and VIQ of the females with a full mutation were 
uncorrelated to the controls* FSIQ and VIQ. It is remark­
able that a significant relation between PIQ of females 
with a full mutation and their controls was found.
Molecular Characteristics o f  the Full Mutation and the 
Mental Status
The full mutation in the FMR1 gene in females can 
be characterized by different features, such as size of the 
mutation and localization on the active or inactive X 
chromosome. No relation between the size of the full 
FMR1 mutation, whether characterized by smallest, av­
erage, or largest size, and the IQ level of the females 
was observed in this study. These findings are inconsis­
tent with earlier reports by Abrams et al. (1994) and
Rousseau et ah (1994), but they are in line with the 
reports from other groups (Rousseau et al. 1991b; Tay­
lor et al. 1994; Reiss et al. 1995) (table 2). Because a 
relation between size and IQ level could not be detected 
in males (De Vries et al. 1993; Loesch et al. 1993), it
would be unlikely to observe such relationship in fe­
males. This corresponds with the characteristics of the 
full mutation in the FMR1 gene. Independent of the size 
of a full mutation, the full mutation is associated with 
méthylation of a CpG island in front of the FMR1 gene, 
leading to an absence of FMR1 protein.
As in other X-linked disorders, lyonization may in­
fluence the phenotypic expression of the normal allele 
in females with a full mutation in the FMR1 gene. Earlier 
studies using cytogenetic techniques in lymphocytes ex­
plored whether the normal X chromosome is more fre­
quently the active (or early replicating) X chromosome 
in carrier females with a normal intelligence compared 
to carriers with an intellectual impairment. Although 
some studies confirmed the relation between a high per­
centage of normal active X chromosomes and normal 
intelligence (Knoll et al. 1984; Paul et al. 1984; Wilhelm 
et al. 1988), others did not (Nielsen et al. 1983; Fryns 
et al. 1984). With molecular techniques, the proportion 
of normal FMR1 alleles on the active X chromosome
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can be estimated more accurately by using methylation 
assays. The cells with normal active FMR1 alleles are 
actually capable of producing FMR1 protein. In the 27 
females with a full mutation only, the normal FMR1 
alleles were significantly more frequent on the active X 
chromosome in intellectually higher-functioning females 
than in females with a mental impairment. This confirms 
earlier findings (Abrams et al. 1994; Rousseau et al. 
1991b; Reiss et al. 1995) but contradicts two other stud­
ies (Rousseau et al. 1994; Taylor et al. 1994) (table 2). 
In the study by Rousseau et al. (1994), the intelligence 
level was clinically estimated without specific IQ  testing, 
and therefore the relation might have been missed. Tay­
lor et al. (1994) included females with a mosaic pattern 
(premutation and full mutation). Although we did not 
observe a difference of the FSIQ between females with a 
full mutation versus mosaics, the effects of an additional 
premutation on the phenotype have not been fully as­
sessed in larger controlled studies. Therefore, including 
c‘mosaic51 females might influence the results. Another 
reason for excluding “mosaic53 females is the inability 
to establish the percentage of normal active X chromo­
somes accurately in these cases.
We observed an age-independent, skewed X inactiva­
tion in leukocytes favoring the X-chromosomes with 
normal FMR1 alleles over those with a full-mutation 
FMR1 allele in females both with normal and subnormal 
intelligence level. This suggests a positive selection for 
leukocytes able to produce FMR1 protein earlier in life. 
Some groups (Rousseau et al. 1991^ 1994; Taylor et 
al. 1994) observed an age-dependent selection in leuko­
cytes: a higher proportion of active X chromosomes car­
rying the normal FMR1 gene in elderly women with a 
full mutation compared to younger females. Because 
only adults were included in the present study, we could 
not observe such an age-dependent selection.
In each cell, the X inactivation occurs at random in 
the late blastocyst stage (Nesbitt 1971; McMahon et al. 
1983; Lyon 1994). The precursor cells for both brain 
and blood formation are the embryonic ectodermal cells, 
which undergo X inactivation around the 2d wk of em­
bryonic development. The X-inactivation distribution is 
rather consistently equal when different tissues within 
one individual are compared, both in mice and men
(Nesbitt 1971; Fialkow 1973, McMahon et al. 1983; 
Kolehmainen and Karant 1994). Because we observed 
females with a high proportion of normal FMR1 alleles 
(>.80) with either a normal or a subnormal IQ level, 
the currently observed relation is likely influenced by the 
age-dependent selection for normal FMR1 expression 
in leukocytes. We hypothesize that the proportion of 
inactivation of the normal X chromosome at the late 
blastocyst stage in some individuals is < .5  and in others 
> .5 . Individuals with a lower proportion of normal ac­
tive X chromosome in the brain will have subnormal 
intelligence, while individuals with a higher proportion 
will be normal. There will be a relation between the 
proportion of normal FMR1 alleles on the active X chro­
mosome in the brain and IQ. In leukocytes, however, 
there is selection for normal X chromosomes, leading 
to a change in the proportion of normal X chromo­
somes. This change is more likely to be higher in individ­
uals with a low proportion of normal X chromosomes, 
disturbing the relationship between proportion of nor­
mal alleles and IQ. The presently observed relation be­
tween a higher proportion of normal FMR1 alleles on 
the active X chromosomes in leukocytes and a higher 
intelligence in females with a full m utation might still 
be a reflection of the distribution of X inactivation in 
brain cells. To prove this hypothesis, we propose to 
study the X-inactivation pattern in other tissues that 
might lack this selection phenomenon. Studies on pro­
tein expression in neuronal cells of either females with 
a full mutation or heterozygous knock-out mice might 
give the relevant clues.
The currently observed relation between molecular 
parameters and the FSIQ were also significant for the 
subcomponent PIQ but not for VIQ. This is in line with 
a recent report about girls with a full mutation, in which 
a stronger relation between the proportion of normal 
active X was suggested for PIQ than for VIQ (Reiss et 
al. 1995). Since the PIQ is less influenced by cultural 
factors than is the VIQ (Cattel 1963; H orn  1968), the 
PIQ seems preferable over the VIQ and FSIQ as an indi­
cator of mental developmental capabilities in molecular- 
cognitive association studies.
The mental status in females with the full mutation 
is influenced by several factors. Besides the full mutation 
in the FMR1 gene, other genetic and environmental fac­
tors may play, to an unknown extent, a role in intellec­
tual development. In this first study of comparing full 
m utation FMR1 female carriers with their noncarrier 
sisters, those shared factors were less significant, re­
flecting a dominant effect of the FMR1 gene full m uta­
tion on mental development in a majority of females 
with a full mutation. This finding will be relevant in the 
genetic counseling of carriers of (pre-)mutations of the 
fragile X syndrome. X-inactivation studies during prena­
tal diagnosis in female pregnancies with a full FMR1 
m utation will not allow a reliable prognosis of the intel­
lectual development of such a child. Henceforth, parents 
will have to decide on the general risk estimates for 
intellectual impairment in female pregnancies with a full 
m utation as observed in this study.
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